A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer

Bookmark and Share
Published: 13 May 2020
Views: 173
Rating:
Save
Prof Nickolas Papadopoulos - Johns Hopkins Medicine, Baltimore, USA

Prof Nickolas Papadopoulos speaks to ecancer about a first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer.

He explains that the study was carried out prospectively in order to mimic real world situations and be able to test individuals who had no suspicion of cancer.

Prof Papadopoulos describes how a PET-CT would be carried out if there was a suspicion of cancer in order to validate and localise a lesion.

He believes that the blood test can be integrated in to the standard of care screening rather than replacing it.